Judge Won’t Exclude Tylenol Liver Injury Study From 1st MDL Bellwether Case
Mealey's (July 18, 2016, 2:30 PM EDT) -- PHILADELPHIA — The Pennsylvania federal judge overseeing the Tylenol multidistrict litigation on July 14 denied a defense motion to exclude a key study from the plaintiff’s case in the first bellwether trial and excluded testimony by defense experts who criticized the reliability of the study (In Re: Tylenol [Acetaminophen] Marketing, Sales Practices, and Products Liability Litigation, MDL Docket No. 2436, No. 13-md-2436, E.D. Pa. 2016 U.S. Dist. LEXIS 92334).
(Opinion available. Document #28-160728-003Z.)
Plaintiffs in the MDL in the U.S. District Court for the Eastern District...